Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 12;29(16):3826.
doi: 10.3390/molecules29163826.

Effect of the Addition of Inorganic Fillers on the Properties of Degradable Polymeric Blends for Bone Tissue Engineering

Affiliations

Effect of the Addition of Inorganic Fillers on the Properties of Degradable Polymeric Blends for Bone Tissue Engineering

Stanisław Marecik et al. Molecules. .

Abstract

Bone tissue exhibits self-healing properties; however, not all defects can be repaired without surgical intervention. Bone tissue engineering offers artificial scaffolds, which can act as a temporary matrix for bone regeneration. The aim of this study was to manufacture scaffolds made of poly(lactic acid), poly(ε-caprolactone), poly(propylene fumarate), and poly(ethylene glycol) modified with bioglass, beta tricalcium phosphate (TCP), and/or wollastonite (W) particles. The scaffolds were fabricated using a gel-casting method and observed with optical and scanning electron microscopes. Attenuated total reflectance-Fourier transform infrared (ATR-FTIR), differential scanning calorimetry (DSC), thermogravimetry (TG), wettability, and degradation tests were conducted. The highest content of TCP without W in the composition caused the highest hydrophilicity (water contact angle of 61.9 ± 6.3°), the fastest degradation rate (7% mass loss within 28 days), moderate ability to precipitate CaP after incubation in PBS, and no cytotoxicity for L929 cells. The highest content of W without TCP caused the highest hydrophobicity (water contact angle of 83.4 ± 1.7°), the lowest thermal stability, slower degradation (3% mass loss within 28 days), and did not evoke CaP precipitation. Moreover, some signs of cytotoxicity on day 1 were observed. The samples with both TCP and W showed moderate properties and the best cytocompatibility on day 4. Interestingly, they were covered with typical cauliflower-like hydroxyapatite deposits after incubation in phosphate-buffered saline (PBS), which might be a sign of their excellent bioactivity.

Keywords: PLA scaffolds; bone tissue engineering; composite scaffolds; polymer blends; porous scaffolds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Gross morphology (A), optical microphotographs (B), and SEM microphotographs (C,D) of manufactured composite scaffolds.
Figure 2
Figure 2
FTIR spectra of manufactured composite scaffolds.
Figure 3
Figure 3
DSC curves of composite scaffolds evaluated after the first (A) and second (B) heating run.
Figure 4
Figure 4
TG (A) and DTG (B) curves of manufactured composite scaffolds.
Figure 5
Figure 5
Water contact angle of the manufactured composite scaffolds. Representative droplets are shown above each bar, where p * < 0.05, p ** < 0.01, p *** < 0.001.
Figure 6
Figure 6
Remaining mass of manufactured composite scaffolds as a function of the incubation time in PBS.
Figure 7
Figure 7
SEM microphotographs of composite scaffolds before (first panel) and after 28 days of degradation study (second and third panels; magnification 1000 and 5000×) and EDS spectra of the samples (fourth panel).
Figure 8
Figure 8
Metabolic activity (A) and live/dead staining (B) of L929 cells cultured in 10% extracts of composite scaffolds and in control conditions (DMEM), where p * < 0.05, p ** < 0.01, p *** < 0.001.

Similar articles

References

    1. Xue N., Ding X., Huang R., Jiang R., Huang H., Pan X., Min W., Chen J., Duan J.-A., Liu P., et al. Bone Tissue Engineering in the Treatment of Bone Defects. Pharmaceuticals. 2022;15:879. doi: 10.3390/ph15070879. - DOI - PMC - PubMed
    1. Nauth A., Schemitsch E., Norris B., Nollin Z., Watson J.T. Critical-Size Bone Defects: Is There a Consensus for Diagnosis and Treatment? J. Orthop. Trauma. 2018;32:7–11. doi: 10.1097/BOT.0000000000001115. - DOI - PubMed
    1. Perez J.R., Kouroupis D., Li D.J., Best T.M., Kaplan L., Correa D. Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects. Front. Bioeng. Biotechnol. 2018;6:105. doi: 10.3389/fbioe.2018.00105. - DOI - PMC - PubMed
    1. Qu H. Additive Manufacturing for Bone Tissue Engineering Scaffolds. Mater. Today Commun.S. 2020;24:101024. doi: 10.1016/j.mtcomm.2020.101024. - DOI
    1. Koons G.L., Diba M., Mikos A.G. Materials Design for Bone-Tissue Engineering. Nat. Rev. Mater. 2020;5:584–603. doi: 10.1038/s41578-020-0204-2. - DOI

LinkOut - more resources